Kim Maplestone

Kim Maplestone has a diverse work experience in the pharmaceutical and biotech industry. Kim'smost recent position was as the VP of Clinical Operations & Data Management at 4D Molecular Therapeutics, where they have been since February 2019. Prior to that, they served as the Senior Director and Head of Clinical Operations at Aduro Biotech from July 2015 to February 2019.

Before joining Aduro Biotech, they were the Sr. Clinical Program Manager at Ultragenyx Pharmaceutical Inc. from November 2013 to July 2015. Kim also worked as a Consultant, Sr. Clinical Program Manager at Cerexa from February 2013 to November 2013, and as a Consultant, Sr. Clinical Program Manager at Metabolex from July 2012 to February 2013.

Kim gained experience as a Consultant, Clinical Operations Manager at Janssen Alzheimer Immunotherapy from January 2012 to August 2012. Prior to that, they served as a Clinical Program Manager at Ipsen from November 2007 to April 2011.

Kim started their career as a Clinical Research Associate II at Abbott Vascular from August 2006 to November 2007, and earlier as a Clinical Research Associate at Allergan from June 2003 to August 2006.

Kim Maplestone obtained a Bachelor's Degree in Business Administration, Management and Operations from Western Washington University. The duration of this educational pursuit is not provided.